Among these genes, AMH, CLDN4, HAMP, PLXNB3, UCN, and TEK have been incorporated into several immune-related gene signatures for predicting clinical outcomes and survival in ccRCC, yet their specific roles in ccRCC remain to be fully elucidated [31,32,33,34,35]. The gene discussed is AMH; the disease is nonpapillary renal cell carcinoma.